The Brain Trust Accelerator Fund is looking to raise up to $25 million for a fund that will invest in companies developing brain cancer treatments and diagnostics.
Brain Trust has targeted between $20 million and $25 million for what would be the investment firm’s second fund, VentureWire reports. The Brain Trust fund was started by America Online co-founder Steve Case as a sort of partnership between the private sector and nonprofits. Brain disease charities will be given a portion of the management fee and carried interest in the fund that would usually have gone to the general partner, Forbes reported.
So far, Brain Trust has made three investments: Amnestix, a biotech developing therapeutics to improve the human memory; NeuroFluidics, a developer of treatments for neurological disorders; and Satoris, which is creating tests for degenerative brain diseases.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
John Reher, co-founder of Medicus Venture Partners, is Brain Trust’s managing director.
Photo from flckr user BlatantNews.com